This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...
The starting dose of 0.25 mg will now cost Rs 2,712 per week, down from Rs 4,336 earlier, with the new prices effective ...
Bizcommunity on MSN
Explainer: GLP-1s and weight management
One of the areas where GLP-1 analogues have an effect is the hypothalamus, or ‘appetite control centre’ of the brain. The GLP ...
Weight loss refers to a reduction in overall body weight, while fat loss specifically targets excess body fat, improving body ...
Pharmaceutical Technology on MSN
Novo Nordisk latest outlook trim shows “quick momentum loss”
The guidance change marks the latest adjustment Novo has made to its 2025 outlook as the company battles a changing market.
Sun Pharma beat profit forecasts on strong India demand and plans to enter the weight-loss drug market once semaglutide ...
Ozempic maker Novo Nordisk has agreed to a deal that will lower the price of blockbuster weight-loss drugs for millions.
The fight against obesity has become one of the greatest medical challenges of the 21st century, with the World Health Organisation (WHO) warning that over one billion people worldwide including 880 ...
November is Diabetes Awareness Month, and this year Diabetes Canada is launching a new campaign to confront the stigma faced ...
Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U.S. government to expand access to its obesity medicines and re ...
Novo Nordisk cuts Wegovy prices in India by up to 33% to boost access and counter Mounjaro’s growing market lead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results